Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.01 | uM | 9 | 312.50 | 153.73 | 282.00 | 260.00 | 1.0846 | 1.2262 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 318.00 | 260.00 | 1.2231 | 1.6085 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 312.50 | 153.73 | 289.00 | 260.00 | 1.1115 | 1.2994 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 312.50 | 153.73 | 111.00 | 260.00 | 0.4269 | -0.3492 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 312.50 | 153.73 | 307.00 | 260.00 | 1.1808 | 1.4901 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 315.00 | 260.00 | 1.2115 | 1.5760 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 374.00 | 260.00 | 1.4385 | 2.2307 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 312.50 | 153.73 | 291.00 | 260.00 | 1.1192 | 1.3204 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 312.50 | 153.73 | 126.00 | 260.00 | 0.4846 | -0.2308 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 340.00 | 260.00 | 1.3077 | 1.8491 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 335.00 | 260.00 | 1.2885 | 1.7939 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 312.50 | 153.73 | 131.00 | 260.00 | 0.5039 | -0.1902 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 302.00 | 260.00 | 1.1615 | 1.4367 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 304.00 | 260.00 | 1.1692 | 1.4581 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 267.00 | 260.00 | 1.0269 | 1.0713 |
| BT-20 | Lapatinib | 1 | uM | 9 | 312.50 | 153.73 | 345.00 | 260.00 | 1.3269 | 1.9045 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 210.00 | 260.00 | 0.8077 | 0.5090 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 637.00 | 782.75 | 0.8138 | 0.7048 | |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 625.00 | 320.09 | 727.00 | 782.75 | 0.9288 | 0.8887 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 656.00 | 782.75 | 0.8381 | 0.7441 |
| BT-20 | Linsitinib | 10 | uM | 9 | 625.00 | 320.09 | 657.00 | 782.75 | 0.8394 | 0.7461 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 625.00 | 320.09 | 854.00 | 782.75 | 1.0910 | 1.1397 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 842.00 | 782.75 | 1.0757 | 1.1164 |
| BT-20 | Erlotinib | 1 | uM | 9 | 625.00 | 320.09 | 797.00 | 782.75 | 1.0182 | 1.0282 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 625.00 | 320.09 | 826.00 | 782.75 | 1.0553 | 1.0851 |